HOSPITAL-ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION RISK COMPARISONS, PROTON PUMP INHIBITOR VS HISTAMINE-2 RECEPTOR ANTAGONIST, FOR PROPHYLAXIS AND TREATMENT OF STRESS ULCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Azab, Mohamed M.
Doo, Loomee D.
Doo, Daniel
Elmofti, Yousif
Ahmed, Muazer
Cadavona, John Jay
Liu, Xibei
Joo, Moon Kyung
Yoo, Ji W.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)32548-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1609
引用
收藏
页码：S733 / S733
页数：1
相关论文
共 50 条
  • [21] EXAMINING RISK OF C DIFFICILE INFECTION WITH USE OF PROTON PUMP INHIBITOR VS H2 RECEPTOR ANTAGONIST
    Shrestha, Alok
    Kalapurayil, Mathew
    Bailey, Janay
    Deol, Harmeet
    Singh, Raghujit
    Surani, Salim
    CHEST, 2018, 154 (04) : 374A - 374A
  • [22] Proton Pump Inhibitors or Histamine-2 Receptor Antagonist Co-Therapy Decrease the Risk of Upper Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulation: A Systematic Review and Meta-Analysis
    Suchartlikitwong, Sakolwan
    Vutthikraivit, Wasawat
    Mingbunjerdsuk, Thammasak
    Zitun, Mohamed
    Laoveeravat, Passisd
    Shroff, Roshan
    Carrasco, Cinthya
    Nugent, Kenneth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S365 - S365
  • [23] Intermittent vs Continuous Proton Pump Inhibitor Therapy for High-Risk Bleeding Ulcers A Systematic Review and Meta-analysis
    Sachar, Hamita
    Vaidya, Keta
    Laine, Loren
    JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1755 - 1762
  • [24] Interventions for Stress Ulcer Prophylaxis (SUP) - Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists: An Updated Meta-Analysis
    Deliwala, Smit
    Hamid, Kewan
    Malladi, Srikanth
    Lakshman, Harini
    Jones, Shane
    Leon, Brianna
    Minh Thu An
    Santana, Maria
    Bachuwa, Ghassan
    Chawla, Saurabh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S303 - S304
  • [25] Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically III Patients: A Systematic Review and Meta-Analysis
    Alhazzani, Waleed
    Alenezi, Farhan
    Jaeschke, Roman Z.
    Moayyedi, Paul
    Cook, Deborah J.
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 693 - 705
  • [26] Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review
    Al Momani, Laith A.
    Abughanimeh, Omar
    Boonpheng, Boonphiphop
    Gabriel, Joseph Gabriel
    Young, Mark
    CUREUS, 2018, 10 (06):
  • [27] Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: A Systematic Review and Meta-analysis
    Furuya-Kanamori, Luis
    Stone, Jennifer C.
    Clark, Justin
    McKenzie, Samantha J.
    Yakob, Laith
    Paterson, David L.
    Riley, Thomas V.
    Doi, Suhail A. R.
    Clements, Archie C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (02): : 132 - 141
  • [28] Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis
    Yao, Dominic Wen Jie
    Ong, Chengsi
    Eales, Nichola Mary
    Sultana, Rehena
    Wong, Judith Ju-Ming
    Lee, Jan Hau
    JOURNAL OF PEDIATRICS, 2021, 228 : 164 - +
  • [29] Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model
    Seo, Seung In
    You, Seng Chan
    Park, Chan Hyuk
    Kim, Tae Joon
    Ko, You Sang
    Kim, Yerim
    Yoo, Jong Jin
    Kim, Jinseob
    Shin, Woon Geon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (08) : 1325 - 1330
  • [30] COMPARATIVE RISK OF CLOSTRIDIUM DIFFICILE INFECTION BETWEEN PROTON PUMP INHIBITORS AND HISTAMINE-2 RECEPTOR ANTAGONISTS: A-15 YEAR HOSPITAL COHORT STUDY USING A COMMON DATA MODEL
    Seo, Seung In
    You, Seng Chan
    Park, Chan Hyuk
    Kim, Tae Jun
    Shin, Woon Geon
    GASTROENTEROLOGY, 2020, 158 (06) : S978 - S978
12345